Submitted by admin on Fri, 04/27/2012 - 12:09
Vernalis Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier
CytRx CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer
Cryolife CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Repligen Repligen hit by FDA setback, shares plummet 41 percent